{
  "docId": "019de514-b808-755e-8f46-3355c3a68f91",
  "docSlug": "726904051bada761abf371aad4bc9c4e",
  "documentTitle": "Avantor | Investor Conference Presentation Deck | 26 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 26,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-b808-755e-8f46-3355c3a68f91/14",
  "deckHref": "/decks/019de514-b808-755e-8f46-3355c3a68f91",
  "deckJsonHref": "/decks/019de514-b808-755e-8f46-3355c3a68f91.json",
  "deckAnchorHref": "/decks/019de514-b808-755e-8f46-3355c3a68f91#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.703,
        "w": 0.309,
        "x": 0.033,
        "y": 0.197
      },
      "kind": "chart",
      "text": "BIOPHARMA PRODUCTION OPEN ORDERS; Single-use; Process Ingredients & Excipients; 2019, 2020, 2021; 5X",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e26226f-7395-4735-94ae-a832c03b3810",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.703,
        "w": 0.652,
        "x": 0.317,
        "y": 0.197
      },
      "kind": "diagram",
      "text": "RECENT CAPACITY INVESTMENTS; 2021: Hydration expansion Europe, Lipids expansion St. Louis, MO, Tris HCL, L-Tyrosine expansions Sanborn, OH, Solvents expansion Phillipsburg, NJ, HPLE sugars expansion St. Louis, MO, Acetonitrile expansion Chester, CT; 2022: Salt buffers expansion Phillipsburg, NJ & Paris, KY, Amino acids production Aurora, OH, Hydration expansion Aurora, OH",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8c8fa37-e839-453c-9239-eec25fd3eb3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.276,
        "x": 0.646,
        "y": 0.942
      },
      "kind": "source-note",
      "text": "40th Annual J.P. Morgan Healthcare Conference",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "057cc4c1-48c9-4494-9a3a-e83bca8a1653",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.78,
        "x": 0.033,
        "y": 0.11
      },
      "kind": "title",
      "text": "Addressing growing demand with critical investments in people, products and capacity",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e58d2320-1133-4c8a-ba46-faff4695cc1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.78,
        "x": 0.033,
        "y": 0.067
      },
      "kind": "title",
      "text": "Investing for growth in biopharma end market",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ce8a879-4743-482e-b136-7c1f4e5e8917",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 9,
      "beatId": "267820d8-3011-4530-b4df-284db2c12563",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "The deck presents various financial metrics, including top-line and bottom-line growth, and 2022 full-year guidance.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 14,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "af9ea1b0-0c37-498f-86cd-45aad9dd494e",
      "evidence": "The deck presents investments as a key driver of growth in the biopharma end market.",
      "position": 1,
      "objective": "To highlight the importance of investing in growth",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}